Kalinsky, Kevin http://orcid.org/0000-0002-1583-3553
Spring, Laura
Yam, Clinton
Bhave, Manali Ajay
Ntalla, Ioanna
Lai, Catherine
Sjekloca, Nikoleta
Stwalley, Brian
Stokes, Michael
Taylor, Aliki
Nanda, Rita
Funding for this research was provided by:
Gilead Sciences, Inc.
Article History
Received: 8 January 2024
Accepted: 13 June 2024
First Online: 21 June 2024
Declarations
:
: KK reported consulting/advisory/speaker role for Daiichi Sankyo, Eli Lilly, Pfizer, Novartis, Eisai, AstraZeneca, Immunomedics, Merck, Seattle Genetics, Cyclacel, OncoSec, 4D Pharma, Puma, Genentech, Ascendant, Myovant, Takeda, and Menarini; and owns Grail stock options. LS reported consulting/advisory role Novartis, Puma, G1 Therapeutics, Daiichi Pharma, AstraZeneca, and Eli Lilly; research grants, paid to her institution, with Merck, Genentech, Gilead Sciences, Inc., and Eli Lilly. CY reported consulting/advisory role for Gilead Sciences, Inc.; research grant from GSK; and additional, non-financial interests from Amgen, Astellas, Genentech, Gilead Sciences, Inc., Merck, Novartis, and Pfizer. MAB reported consulting/advisory/speaker role for AstraZeneca, Daiichi Sankyo, Pfizer, OncLive, Curio, Targeted Oncology, and Merck. IN, CL, NS, BS, and AT are employees of Gilead Sciences, Inc. and own Gilead Sciences, Inc. stock options. MS is an employee of Evidera; Evidera has received funding from Gilead Sciences, Inc. for conducting the analysis of this study. RN reported consulting/advisory role for AstraZeneca, BeyondSpring, Daiichi Sankyo, Fujifilm, GE, Gilead Sciences, Inc., Infinity, iTeos, MacroGenics, Merck, Novartis, OBI Pharma, OncoSec, Pfizer, Sanofi, Seagen, and Stemline; and research grants from Arvinas, AstraZeneca, Celgene, Corcept Therapeutics, Genentech/Roche, Gilead/Immunomedics, Merck, Novartis, OBI Pharma, OncoSec, Pfizer, Relay, Seattle Genetics, Sun Pharma, and Taiho.
: This observational study was performed in accordance with ethical principles that are consistent with the Declaration of Helsinki, International Conference on Harmonisation (ICH) Good Clinical Practice (GCP), and the applicable legislation on non-interventional studies and/or observational studies.
: This research study was conducted retrospectively using de-identified data from the existing dataset of electronic health record data. This research did not involve direct enrollment of any patients and personal identifiable data was not collected; thus, consents to participate or publish were not collected.